Veracyte, Inc.

VCYTNASDAQ • USD
ThemeGenomics & Precision Med.›Genetic Testing & Diagnostics
49.94 USD
↗ 1.25 (2.57%)AT CLOSE (11:59 AM EDT)
49.70
↘ 0.25 (0.49%)
POST MARKET (AS OF 07:33 PM EDT)
Post Market
AS OF 07:33 PM EDT
49.70
↘ 0.25 (0.49%)
🔴Market: CLOSED
Open?$49.30
High?$50.54
Low?$48.70
Prev. Close?$48.69
Volume?1.6M
Avg. Volume?1.1M
VWAP?$49.91
Rel. Volume?1.48x
Bid / Ask
Bid?$42.86 × 100
Ask?$56.93 × 100
Spread?$14.07
Midpoint?$49.89
Valuation & Ratios
Market Cap?3.9B
Shares Out?79.8M
Float?77.9M
Float %?98.6%
P/E Ratio?44.14
P/B Ratio?2.89
EPS?$1.10
Dividend?0.00%
Ex-Dividend?N/A

Veracyte, Inc. (VCYT) is currently trading at $49.98. Technical and fundamental signals align bullish — technicals rate "Strong Buy" while fundamentals indicate "Buy". This is driven by a robust Altman Z-Score and a bullish Golden Cross on the moving averages. On the valuation front, VCYT trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 4, 2026.

RelatedTWST
News
Profile
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Themes
Healthcare - Genomics & Precision Medicine›Genetic Testing & DiagnosticsHealthcare - Oncology›Cancer Diagnostics & Biomarkers
Employees
755
Market Cap
3.9B
Industry
SERVICES-MEDICAL LABORATORIES
Website
www.veracyte.com
Listed
2013-10-30
Address
6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 243-6300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
100
Momentum?
83
Short Sent.?
24
Piotroski F-Score?6/9Mixed
Altman Z-Score?46.04Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.02%High
Short Interest?8.6M
Days to Cover?7.2
Free Float77.9M
Avg Daily Volume1.2M
Settlement Date2026-05-15
Financial Health
Current Ratio?9.31Strong
Quick Ratio?8.92Strong
Cash Ratio?4.69Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
S&P
16
44.1PRICEY▾
P/B?
Peers
100
S&P
58
2.89CHEAP▾
P/S?
Peers
100
S&P
16
7.17HIGH▾
P/FCF?
S&P
39
25.0FAIR▾
EV/EBITDA?
S&P
10
30.3HIGH▾
EV/Sales?
Peers
100
S&P
22
6.69HIGH▾
Returns & Efficiency
ROE?
S&P
22
6.6%FAIR▾
ROA?
S&P
54
6.1%FAIR▾
Cash Flow & Enterprise
FCF?$155.3M
Enterprise Value?$3.6B
Fundamentals ratios updated end of day
MarketsMoversWatchlist